Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02689011
Other study ID # CTU / UriKANE / 2013
Secondary ID
Status Completed
Phase N/A
First received February 7, 2016
Last updated February 25, 2016
Start date January 2014
Est. completion date January 2015

Study information

Verified date February 2016
Source Aga Khan University
Contact n/a
Is FDA regulated No
Health authority Pakistan: Aga Khan University Ethical Review Committee
Study type Interventional

Clinical Trial Summary

This study aims to compare the incidence of urinary retention and requirement of bladder catheterization in patients undergoing total knee arthroplasty while receiving either continuous epidural analgesia or single shot femoral nerve block.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date January 2015
Est. primary completion date January 2015
Accepts healthy volunteers No
Gender Both
Age group 30 Years to 70 Years
Eligibility Inclusion Criteria:

- ASA Physical status I, II & III

- Male and Female Patients age between between 30 and 70 years

- Unilateral Total Knee Arthroplasty

Exclusion Criteria:

- Patient Refusal

- Allergy to local anesthetics, paracetamol or other study drugs

- History of opioid dependence

- Contraindications to spinal/epidural anesthesia and femoral nerve block (coagulation defects, infection at puncture site etc.)

- Inability to use patient-controlled analgesia (IV PCIA) (as assessed at the time of informed consent)

- History of urinary retention, neurogenic bladder, or any urologic problem

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label


Intervention

Procedure:
Femoral Nerve Block
For patients in Femoral nerve Block Group (Group F), ultrasound guided Femoral nerve block was performed using 0.375% bupivacaine, 20 ml for femoral nerve
Epidural
Patients in Epidural Group (Group E) were turned in lateral position for epidural catheter placement in lumbar region. Epidural was loaded with 0.25% bupivacaine and infusion of M2 (Bupivacaine 0.1% + Fentanyl 2mcg/ml) was started at 8 - 12 ml per hour.

Locations

Country Name City State
Pakistan Aga Khan University Karachi

Sponsors (1)

Lead Sponsor Collaborator
Aga Khan University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of urinary retention To compare the incidence of urinary retention in patients undergoing unilateral Total Knee Arthroplasty receiving continuous epidural analgesia vs. single shot Femoral Nerve Block. 24 Hours No
Secondary Mean post-operative nausea and vomiting scores To compare the mean post-operative nausea and vomiting scores between the two groups at 0, 1, 12, 24 & 48 hours postoperatively. up to 48 hours No
Secondary Mean post-operative sedation scores To compare the mean post-operative sedation scores between the two groups at 0, 1, 12, 24 & 48 hours postoperatively. up to 48 hours No
Secondary Mean post-operative pain scores To compare the mean post-operative pain scores between the two groups at 0, 1, 12, 24 & 48 hours postoperatively. up to 48 hours No
Secondary Surgical outcomes - maximal knee flexion To compare surgical outcomes like maximal knee flexion at 24 & 48 hours between the two groups up to 48 hours No
Secondary Surgical outcomes - duration of post-operative hospital stay To compare surgical outcomes like duration of post-operative hospital stay between the two groups up to 48 hours No
Secondary Surgical outcomes - mobilization out of bed To compare surgical outcomes like time taken to mobilize out of bed between the two groups up to 48 hours No
Secondary Surgical outcomes - food intake To compare surgical outcomes like time of first food intake between the two groups up to 48 hours No
Secondary Patient satisfaction To compare Patient satisfaction with the analgesic modality between the two groups 7 Days No
See also
  Status Clinical Trial Phase
Completed NCT04484610 - Appropriate Opioid Quantities for Acute Pain - Pharmacist Study Phase 4
Recruiting NCT05054179 - Pecto-Intercostal Fascial Plane Block Catheter Trial for Reduction of Sternal Pain Phase 2/Phase 3
Completed NCT04548635 - VR for Burn Dressing Changes at Home Phase 2/Phase 3
Recruiting NCT05370404 - Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain: N/A
Completed NCT06054945 - Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block
Completed NCT03825549 - A Randomized Trial of Behavioral Economic Approaches to Reduce Unnecessary Opioid Prescribing N/A
Completed NCT05995912 - Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain Phase 2
Recruiting NCT05589246 - Regional Analgesia in Combination With Cryoanalgesia to Prevent Acute Pain Following Nuss Procedure N/A
Recruiting NCT05572190 - Evaluate the Safety and Pharmacokinetic Profile of ETR028 and ETR029 in Healthy Adult Subjects Phase 1
Terminated NCT04716413 - Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment Phase 4
Active, not recruiting NCT03537573 - Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care N/A
Not yet recruiting NCT06317844 - Examination of Psychological and Physiological Pathways Linking Gratitude and Pain N/A
Withdrawn NCT02957097 - Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures Phase 4
Completed NCT02565342 - Interscalene Brachial Plexus Block to Treat Pain After Clavicular Surgery Phase 4
Terminated NCT02599870 - Clinical Study to Evaluate Clinical Impact of PGx-Guided Treatment for Patients Undergoing Elective Spinal Surgical Procedures N/A
Completed NCT02380989 - Integrative Ayurveda Healing Relieves Minor Sports Injury Pain Phase 2
Completed NCT02984098 - 40% Orally Administered Dextrose Gel is More Effective Than 25% Dextrose Phase 4
Completed NCT03107338 - Preventive Treatment of Pain After Dental Implant Surgery Phase 4
Completed NCT02489630 - Low Dose Ketamine as an Adjunct to Opiates for Acute Pain in the Emergency Department Phase 4
Completed NCT02817477 - Intranasal Ketamine for Acute Traumatic Pain Phase 4